Clinical Trials Browser

Phase 1/2 × Unknown × pelcitoclax × Clear all

NCT05186012 2024-01-23

APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma

Phase 1/2 Unknown

Lymphoma, Non-Hodgkin